HRT Financial’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-103,663
Closed -$1.45M 4169
2026
Q1
$1.45M Sell
103,663
-58,810
-36% -$792K ﹤0.01% 1818
2025
Q4
$1.82M Sell
162,473
-24,264
-13% -$278K 0.01% 1367
2025
Q3
$2.16M Buy
186,737
+85,196
+84% +$998K 0.01% 1104
2025
Q2
$1.24M Buy
101,541
+72,458
+249% +$911K 0.01% 1159
2025
Q1
$416K Buy
+29,083
New +$454K ﹤0.01% 1569
2024
Q4
Sell
-27,112
Closed -$651K 2423
2024
Q3
$651K Buy
+27,112
New +$620K ﹤0.01% 1455
2024
Q2
Sell
-20,509
Closed -$408K 2205
2024
Q1
$408K Sell
20,509
-3,086
-13% -$59.7K ﹤0.01% 1367
2023
Q4
$529K Buy
+23,595
New +$487K ﹤0.01% 1331
2023
Q3
Sell
-11,325
Closed -$289K 2386
2023
Q2
$289K Buy
+11,325
New +$298K ﹤0.01% 1648
2022
Q4
Sell
-18,288
Closed -$398K 2451
2022
Q3
$398K Buy
18,288
+688
+4% +$18K ﹤0.01% 1812
2022
Q2
$481K Buy
17,600
+7,667
+77% +$220K 0.01% 1670
2022
Q1
$332K Buy
+9,933
New +$320K ﹤0.01% 2165
2021
Q4
Sell
-17,273
Closed -$538K 3169
2021
Q3
$538K Buy
17,273
+9,856
+133% +$334K ﹤0.01% 1905
2021
Q2
$269K Sell
7,417
-716
-9% -$29.6K ﹤0.01% 2215
2021
Q1
$355K Buy
+8,133
New +$382K ﹤0.01% 2014
2020
Q4
Sell
-12,568
Closed -$417K 1836
2020
Q3
$417K Buy
+12,568
New +$402K 0.01% 967

Other funds holding AVNS

HRT Financial's AVNS Position: Q2 2026 in Review

HRT Financial sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 103,663 shares — an estimated $1.45M sold.

HRT Financial first reported a position in AVNS in Q3 2020 and held it in 16 quarters. The position peaked at $2.16M in Q3 2025. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • HRT Financial reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 103,663 Avanos Medical shares in Q2 2026, an estimated $1.45M.
  • HRT Financial first reported a position in Avanos Medical in Q3 2020 and held it in 16 quarters.
  • HRT Financial's Avanos Medical position peaked at $2.16M in Q3 2025.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.